The Cardiff-based medical technology firm raised pre-seed funding led by SFC Capital and OVC Ventures to expand its home diagnostic tools.
"By empowering patients with innovative tools and ensuring they are remotely monitored by clinicians, we’re shaping the future of healthcare to be more accessible, personalised, and efficient. We are grateful to our investors and grant partners for their support in making this vision a reality."
JuneX Capital Partners joins the ongoing pre-seed round of the London-based edtech startup.
"This isn't just funding — it's validation of our mission and a partnership that energizes our journey. Building a startup is hard — finding the right talent, making first sales, raising funds — it's all HARD. But milestones like this prove that you can do hard things. We are thrilled to have JuneX Capital Partners supporting our vision to transform education."
The seed round was led by a Dubai-based investment group with backing from individual technology investors.
"Parenting has never been so tough and each new generation is burdened with more stress than the last. We don’t think it should be this way and believe that there’s a solution in technology to not only help us remove some of the stress that comes with being a modern-day parent, but also make things easier and happier for us and our children."
Tewke closed an oversubscribed seed round to accelerate the development and market rollout of its home energy optimisation platform.
"There have been small movements towards adopting more energy efficient systems, and smart-home technologies, but there has always been a lack of a fully integrated system that can autonomously automate energy savings, and Tewke is changing that. Often energy savings are associated with some kind of compromise, but at Tewke we are building a platform that will elevate people’s homes, making them more environmentally friendly, intuitive and secure."
The funding round was backed by British Design Fund to accelerate product development and market reach.
"Pain and joint conditions, collectively known as musculoskeletal (MSK) conditions, affect 20m people in the UK and 1.7bn people globally. Many of these disorders can be effectively treated and managed through water-based therapeutic interventions. However, until now, we have been unable to measure movement in water to assess the power, speed or range of movement with any accuracy. We’re delighted to say Good Boost has cracked that engineering challenge."